Developing single dose, non-surgical sterilization methods for wild animal populations

Aerial shooting, poisoning, and trapping of pigs, wolves, camels, and other wild animal populations are costly, inhumane, and largely ineffective. 

Targeted, species-specific viral delivery of reproductive-suppressing proteins represents a humane, cost-effective, and scalable alternative. 

While the underlying technological platforms to achieve these goals exist today, species-specific vaccines must still be developed—requiring investment and adoption by government and wildlife management agencies.

Creating new, low cost options for stray and wild animal sterilization

Disarmed species specific viral vectors, like those used for targeted human cancer therapeutics can be used to deliver safe, permanent, non-surgical sterilization to female (and possibly male) dogs and cats at a fraction of the cost of spaying or neutering animals. 

These low cost technologies would save tens of millions of dollars in state and county shelter system budgets, and reduce the burden of compliance with city and state ordinances for private pet owners. 

Building gene therapeutics for wild and domesticated animal populations

Species-specific vaccines engineered to deliver therapeutics and beneficial proteins to wild animal and pet populations offer immense potential to address severe disease in animal populations including African Swine Fever (ASF), Swine Influenza Virus (SIV), and Avian Influenza Virus (AIV).